The distinction between ALK- ALCL and PTCL-NOS with large cells and CD30 expression (CD30+ PTCL-NOS, approximately 10% of cases) is not only challenging but is also prone to subjectivity. Here, TNFRSF8 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.